Skip to main content
Senzime logo

Senzime — Investor Relations & Filings

Ticker · SEZI ISIN · SE0002478776 LEI · 549300JQF174JP0MM382 ST Manufacturing
Open in API
Filings indexed 216 across all filing types
Latest filing 2022-11-10 Interim / Quarterly Rep…
Country SE Sweden
Listing ST SEZI

About Senzime

https://senzime.com/en

Senzime is a medical device company that develops and markets precision-based patient monitoring solutions designed to enhance patient safety. The company's primary focus is on systems for neuromuscular and respiratory monitoring during and after surgery. Its flagship product, the TetraGraph, is an algorithm-powered monitor that provides quantitative train-of-four (TOF) monitoring based on electromyography (EMG) technology. This enables clinicians to precisely manage neuromuscular blockade, reduce postoperative complications, and improve patient outcomes. Senzime's technology supports the adoption of new clinical guidelines, aiming to establish a higher standard of care in anesthesia and recovery.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive quarterly financial report for Senzime AB, covering the period of July-September 2022 and January-September 2022. It contains detailed financial statements, including income statements, balance sheet summaries, and management commentary on financial performance, revenue growth, and operational updates. It is not an announcement of a report (RPA) or a simple earnings release (ER), as it provides substantive financial data and analysis consistent with an interim report. 9M 2022
2022-11-10 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for the period of January to September 2022, explicitly titled 'Interim Report January - September 2022'. It contains detailed financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance, which aligns perfectly with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-10 English
KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I SENZIME AB (PUBL)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I SENZIME AB (PUBL)" which translates to "COMMUNIQUÉ FROM THE EXTRAORDINARY GENERAL MEETING OF SENZIME AB (PUBL)". It details the decisions made regarding the board of directors during this meeting. An Extraordinary General Meeting (EGM) is a type of general meeting, and the decisions made, especially concerning board composition, are related to shareholder voting and governance. Since the document explicitly reports the results and decisions of a shareholder meeting (Extra Bolagsstämma), the most fitting category is related to shareholder voting results or general meeting information. 'AGM-R' covers AGM materials, but this is an EGM. 'DVA' (Declaration of Voting Results & Voting Rights Announcements) is the best fit as it covers official results from shareholder votes at *any* general meeting. The document is a press release summarizing the outcomes, not the full presentation or minutes.
2022-08-31 Swedish
COMMUNIQUE FROM EXTRAORDINARY GENERAL MEETING IN SENZIME AB (PUBL)
AGM Information Classification · 1% confidence The document is explicitly titled "COMMUNIQUE FROM EXTRAORDINARY GENERAL MEETING IN SENZIME AB (PUBL)". It details resolutions passed during this meeting, specifically concerning the election of new members to the Board of Directors. This content directly relates to the proceedings and outcomes of a general meeting. The most appropriate classification among the provided options is AGM-R (AGM Information), as an Extraordinary General Meeting (EGM) functions similarly to an AGM regarding shareholder resolutions and board changes, and AGM-R is the closest fit for general meeting outcomes, especially when DVA (Declaration of Voting Results) is less specific about the content being the resolutions themselves rather than just the final tally. Given the content focuses on the resolutions passed, AGM-R is the best fit.
2022-08-31 English
Senzime erhåller FDA 510k-godkännande för ny engångssensor avsedd för monitorering av barn
Regulatory Filings Classification · 1% confidence The document is titled "PRESSMEDDELANDE" (Press Release) and is dated August 18, 2022. It announces a specific corporate event: Senzime receiving FDA 510k clearance for a new product (TetraSens Pediatric sensor). It includes quotes from the CEO and contact information, typical of a news announcement. Crucially, at the end, it lists an attachment and states, "Denna information är sådan information som Senzime är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning." (This information is such information that Senzime is obliged to disclose pursuant to the EU's Market Abuse Regulation). This structure—a brief announcement detailing a material event, often referencing an attached document or linking to the full details—fits the definition of a general regulatory announcement that doesn't fit a more specific category like Earnings Release (ER) or Director's Dealing (DIRS). Since it is a mandatory disclosure under MAR but doesn't fit the specific financial report types (10-K, IR, AR) or specific corporate actions (DIV, CAP, M&A), the most appropriate fallback category is Regulatory Filings (RNS). The document length (3630 chars) is short, suggesting it is the announcement itself, not the full regulatory filing it references.
2022-08-18 Swedish
Senzimes receives FDA 510k-clearance for a new disposable sensor intended for monitoring of children
Legal Proceedings Report Classification · 1% confidence The document is explicitly labeled as a "PRESS RELEASE" and announces a specific regulatory event: receiving FDA 510k-clearance for a new medical sensor. It is short, provides key highlights, and concludes with a section titled "Attachments" linking to the full document, which suggests it is an announcement rather than the comprehensive report itself. This fits the description of a general regulatory announcement or a specific type of announcement that doesn't fit the core financial reports (10-K, IR, ER). Since it is a specific regulatory update that isn't a director's dealing, dividend, or capital change, the most appropriate general category for a non-financial, specific regulatory update that doesn't fit elsewhere is Regulatory Filings (RNS). However, given the nature of the announcement (a specific regulatory clearance), it is a significant event announcement. If we strictly follow the definitions, it is not an Earnings Release (ER), Interim Report (IR), or a standard financial filing. It is a regulatory update. RNS is the fallback for miscellaneous regulatory announcements. Given the context of a press release announcing a specific regulatory milestone, RNS is the best fit among the provided options, as it is not a standard financial report or a specific corporate action like DIRS or DIV.
2022-08-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.